Stock THER THERALINK TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Theralink Technologies, Inc.

Equities

THER

US88339Q1094

Market Closed - OTC Markets
Other stock markets
 03:50:24 2024-05-13 pm EDT 		5-day change 1st Jan Change
0.0006 USD 0.00% Intraday chart for Theralink Technologies, Inc. -14.29% -60.00%
May. 06 Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction. CI
Feb. 20 Theralink Technologies, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Theralink Technologies, Inc. cancelled the acquisition of IMAC Holdings, Inc. in a reverse merger transaction.
CI
Theralink Technologies : Accelaration/Increase of Financial Obligation - Form 8-K
PU
Theralink Technologies, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023
CI
Theralink Technologies, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023
CI
Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates
AQ
Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4
AQ
Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute’s Molecular Tumor Board
AQ
Theralink Technologies, Inc. Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute?s Molecular Tumor Board
CI
Four Penny Stocks That Might Move On News (EPAZ, THER, SDNR, HNRC)
AQ
Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023
AQ
Theralink Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023
CI
IMAC Holdings, Inc. announced that it has received $4.3 million in funding from Theralink Technologies, Inc. and other investors
CI
Theralink Technologies, Inc. Announces Chief Executive Officer Changes
CI
Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer
AQ
Theralink Technologies, Inc. Appoints Mick Ruxin as Chief Medical Officer
CI
Theralink Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023
CI
Theralink Technologies, Inc. entered into a definitive agreement and plan of merger to acquire IMAC Holdings, Inc. for $0.9 million in a reverse merger transaction.
CI
Theralink Technologies, Inc. Announces Termination of Thomas Chilcott as Treasurer and Secretary
CI
Theralink Technologies, Inc. Announces CFO Changes
CI
Theralink Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. THER Stock
  4. News Theralink Technologies, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW